Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Chinese artificial intelligence start-ups Zhipu AI and MiniMax have shown early signs of sustainable commercialisation of their AI models, analysts said, as investors continue to pump up their Hong ...
AMD’s Ryzen AI Max+ 395 Strix Halo processor packs a lot of power into a mobile chip designed for laptops and mini PCs. With integrated graphics that rivals a discrete GPU, it offers an efficient ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results